Jove
Visualize
联系我们
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 瘤学和致癌症
  5. 预测和预后标志物
  6. 调节keap1/nrf2和p53通道以抑制结直肠癌中的铁
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 瘤学和致癌症
  5. 预测和预后标志物
  6. 调节keap1/nrf2和p53通道以抑制结直肠癌中的铁

相关实验视频

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K

调节KEAP1/NRF2和p53通道以抑制结直肠癌中的铁

Hai-Meng Zhou1, Yi Liu2, Feng Shi2

  • 1Wuhan University, Wuhan, Hubei, China.

Cancer research
|August 29, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

通过调节KEAP1/NRF2/HMOX1和p53/SLC7A11通路,CLK2可以抑制结肠直肠癌中的铁. 向CLK2可以提高铁和CRC治疗的疗效.

科学领域:

  • 癌症学
  • 细胞死亡机制
  • 分子生物学

背景情况:

  • 在结肠直肠癌 (CRC) 的进展和治疗中,依赖于铁的细胞死亡是必不可少的.
  • 调节氧化应激和铁的NRF2通路通过像HMOX1 (亲铁) 和SLC7A11 (抗铁) 这样的点影响铁.

研究的目的:

  • 调查CLK2在CRC铁中调节HMOX1和SLC7A11之间的作用.
  • 探索CLK2对CRC增殖和瘤发生的影响.
  • 评估CLK2作为CRC的潜在治疗点.

主要方法:

  • 研究了CLK2对KEAP1,NRF2,p53,HMOX1和SLC7A11的调控.
  • 评估了CLK2对CRC细胞,患者衍生器官和小鼠模型的影响.
  • 在CLK2缺陷模型中评估了Erastin和oxaliplatin的联合治疗.

主要成果:

  • 通过CLK2稳定KEAP1,抑制NRF2活动并降低HMOX1和SLC7A11的活性.
  • 通过CLK2降低p53,缓解SLC7A11的抑制作用.
  • CLK2的丧失导致HMOX1过度激活,使CRC细胞对ferroptosis敏感,并抑制瘤生长.
  • 促进CRC的扩散和瘤发生.

更多相关视频

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.3K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K

相关实验视频

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.2K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.3K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K

相关概念视频

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

7.1K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策
  • 在CLK2缺陷模型中,Erastin和Oxaliplatin联合显示出增强的抗瘤功效.
  • 结论:

    • 通过KEAP1/NRF2/HMOX1和p53/SLC7A11途径,CLK2作为CRC中铁的关键抑制剂.
    • 促进CRC的扩散和瘤发生.
    • CLK2 是一种有前途的治疗点,用于增强基于铁的CRC治疗.